Paul Mampilly’s Advice On One Particular Investment Trend

Published on Author RM2000

Paul Mampilly can smell a great financial investment from a mile away. With over 20 years experience in the financial industry he truly knows from trial and error what will become a good investment and what doesn’t. This comes from a whole lot of research and practice.

Here’s how Paul Mampilly is fit as a financial guru. He first earned his Bachelor of Business Administration in Finance and Accounting from Montclair State University in 1991. Thirsting for more knowledge Paul continued on to get his Master of Business Administration degree in Finance from Fordham Graduate School of Business in 1997. Mr. Mampilly started his career as a assistant portfolio manager on the stock market. Within time he would prove himself as a financial heavy hitter. Paul would be invited later in life to compete in the prestigious Templeton Foundation investment competition. He turned a $50 million dollar fund into $88 million during the financial crisis. Not only did he win the competition, but he really showed everyone how capable as a financial advisor he was. With the help of Kinetics Asset Management heard wind of the successful investor and hired Paul Mampilly on their team. Barron’s said that their Kinetics hedge fund was the world’s best at 26 percent annual returns thanks to the brilliant mind of Paul. It became a $25 billion dollar fund. See more of Paul Mampilly on facebook.

In his newsletter Profits Unlimited Paul Mampilly recommends certain small-cap stocks, technology, special opportunities, and growth investing picks to his audience of Main Street Americans. One of his most recent recommendations is in precision medicine. This type of medicine is going to completely change the face of the healthcare system Paul Mampilly says. It is personalized to each patient by using their personal data. Doctors can look at an individual patient’s DNA to diagnose, treat, and care for the patient. This revolutionary way of treating patients will give them a much accurate and higher change of success. It is a far cry from how we treat people today with a one size fits all mentality. Precision medicine would not only treat and diagnose patients but eradicate diseases like Alzheimer’s, arthritis, heart disease, diabetes, and Parkinson’s disease. How incredible would that be? Mr. Paul Mampilly found a company in particular in the Midwest that is on the forefront of precision medicine and they are called Myriad Genetics. They are a diagnosing company who identifies cancer variants and checks a individuals risk for cancer. Visit: